Use of a pharmacological indicator to monitor compliance with thyroxine.

Autor: Penn, N., Peaker, S., Griffiths, A., Feely, M., Tindall, H.
Zdroj: European Journal of Clinical Pharmacology; 1988, Vol. 35 Issue 3, p327-329, 3p
Abstrakt: Poor compliance with medication is often suspected, but difficult to confirm. The compliance of fourteen newly diagnosed hypothryroid patients was assessed using both TSH levels and low-dose phenobarbitone as a pharmacological marker. The study confirms the value of phenobarbitone as an indicator of compliance over a protracted period and suggests that it could be used to differentiate under-treatment from poor compliance. [ABSTRACT FROM AUTHOR]
Databáze: Complementary Index